In the U.S., an alarming alliance between big pharma, congressional elites, and government agencies is transforming healthcare into a system of control and oppression. Through extensive lobbying and financial contributions, big pharma has captured the legislative process, ensuring healthcare policies prioritize profit margins over patient well-being. Government agencies like the FDA enforce monopolistic practices, restricting access to affordable medications. This article explores the dire consequences of this collusion and calls for reclaiming healthcare freedom by breaking monopolies and expanding access to affordable medications from trusted international sources.